APA

Blicklé J., Hancu N., Piletic M., Profozic V., Shestakova M., Dain M., Jacqueminet S. & Grimaldi A. (20100122). Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study. : Diabetes, obesity & metabolism.

Chicago

Blicklé J-F, Hancu N, Piletic M, Profozic V, Shestakova M, Dain M-P, Jacqueminet S and Grimaldi A. 20100122. Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study. : Diabetes, obesity & metabolism.

Harvard

Blicklé J., Hancu N., Piletic M., Profozic V., Shestakova M., Dain M., Jacqueminet S. and Grimaldi A. (20100122). Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study. : Diabetes, obesity & metabolism.

MLA

Blicklé J-F, Hancu N, Piletic M, Profozic V, Shestakova M, Dain M-P, Jacqueminet S and Grimaldi A. Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study. : Diabetes, obesity & metabolism. 20100122.